During the COVID-19 pandemic in 2020, she began focusing her research on finding a vaccine against SARS-CoV-2, partnering with Pfizer in this effort.[1] On November 11, 2020, Pfizer reported that a COVID-19 vaccine developed by Dr. Türeci and her team is more than 90 percent effective in preventing the disease.[9]